Bankrupt drugmaker Mallinckrodt considers sale of opioid business

By The Wall Street Journal
| September 19, 2023

Some investors, poised to take control through chapter 11, are suggesting the company break up its business units.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...